News Daily News Halving DES Use in Low-Risk Patients Could Save $200 Million Annually Yael L. Maxwell July 11, 2012
News Daily News VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months Caitlin E. Cox June 11, 2012
News Industry News Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure May 16, 2012
News Industry News Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe May 15, 2012
News Daily News La Revascularización Incompleta hace que los Diabéticos corran un Mayor Riesgo de Episodios a Largo Plazo Leah Lawrence April 20, 2012
News Daily News Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events Leah Lawrence April 20, 2012
Presentation Impact of Completeness of Revascularization on Long-term Cardiovascular Outcomes in Patients with Type 2 Diabetes Presenter: Leonard Schwartz April 19, 2012
News Daily News Exenatide Only Cardioprotective in STEMI Patients Treated Quickly Caitlin E. Cox April 16, 2012
News Daily News JAMA Letters Continue Debate Over Genotype, Clopidogrel Response Caitlin E. Cox April 12, 2012
News Daily News Residual Syntax Score Predicts Outcome After Incomplete Revascularization L.A. McKeown April 10, 2012
News Daily News CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact April 10, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Daily News Better Clopidogrel Response Seen with Increased Smoking Levels Jason Kahn March 21, 2012